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ABSTRACT: The development of more complex in vitro
models for the assessment of novel drugs and chemicals is
needed because of the limited biological relevance of animal
models to humans as well as ethical considerations. Although
some human-cell-based assays exist, they are usually 2D,
consist of single cell type, and have limited cellular and
functional representation of the native tissue. In this study, we
have used biomimetic porous electrospun scaﬀolds to develop
an immunocompetent 3D model of the human respiratory
tract comprised of three key cell types present in upper airway
epithelium. The three cell types, namely, epithelial cells (providing a physical barrier), ﬁbroblasts (extracellular matrix
production), and dendritic cells (immune sensing), were initially grown on individual scaﬀolds and then assembled into the 3D
multicell tissue model. The epithelial layer was cultured at the air−liquid interface for up to four weeks, leading to formation of a
functional barrier as evidenced by an increase in transepithelial electrical resistance (TEER) and tight junction formation. The
response of epithelial cells to allergen exposure was monitored by quantifying changes in TEER readings and by assessment of
cellular tight junctions using immunostaining. It was found that epithelial cells cocultured with ﬁbroblasts formed a functional
epithelial barrier at a quicker rate than single cultures of epithelial cells and that the recovery from allergen exposure was also
more rapid. Also, our data show that dendritic cells within this model remain viable and responsive to external stimulation as
evidenced by their migration within the 3D construct in response to allergen challenge. This model provides an easy to assemble
and physiologically relevant 3D model of human airway epithelium that can be used for studies aiming at better understanding
lung biology, the cross-talk between immune cells, and airborne allergens and pathogens as well as drug delivery.
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■ INTRODUCTION
Respiratory diseases such as asthma are becoming increasingly
prevalent, with reduced longevity and quality of life for those
aﬀected as well as causing an economic burden upon healthcare
systems worldwide.1 Consequently, there is a need to develop
more eﬀective therapies to prevent and treat respiratory
diseases. Developing new therapies requires extensive testing
to ensure eﬃcacy and safety, which is both time-consuming and
costly. Therapies that show promise during the ﬁrst stage
preclinical in vitro tests may be taken forward for further
studies. For all new medications, regulatory authorities insist
upon acquiring information from animal studies because the
eﬀect upon the whole body can be observed. However, the
limited biological relevance of animal models to human diseases
means that data obtained from such studies could not always be
relied on.
In vitro models of human tissues that are biomimetic and
closely represent the functional properties of their respective
tissues could enable better understanding of disease processes,
hence providing more physiologically relevant platforms for
identiﬁcation of targets for therapy as well as testing the eﬃcacy
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and safety of new drug leads. Using such in vitro models in drug
discovery cycle could in turn substantially reduce the number of
drug leads that need to be taken forward to preclinical studies
and, therefore, reducing the number of animals required for
such experiments.2 In addition to providing scientiﬁc
advantages (e.g., identiﬁcation of more eﬃcacious targets for
therapy), using biomimetic in vitro tissue models also conforms
with the “3Rs” principles of reﬁnement, replacement, and
reduction of animal experimentations in research wherever
possible.3
The respiratory system is constantly exposed to potentially
harmful particles, allergens, and pathogens. To maintain sterility
of the lung the respiratory system has a series of defense
mechanisms and the capability to respond to environmental
challenges. Epithelial cells are the predominant cell type in
contact with the air and as such the airway epithelium forms the
ﬁrst line of defense against airborne insults. Epithelial cells are
structurally arranged to form a continuous layer and are joined
via protein junctions to create a paracellular barrier to shield
interstitial tissue from the airway. As well as a physical barrier,
the epithelium forms a chemical barrier via cellular secretions,
for example, mucus that entraps inﬁltrating particles.
Furthermore, contact with invading pathogens prompts
epithelial cells to release lysozymes and phospholipase that
destabilize bacterial membranes, defensins that have antimicro-
bial activity, and surfactants that promote phagocytosis of
invading particles.4
If the epithelial barrier is compromised, the epithelial cells
not only change morphologically and functionally but also
communicate reciprocally via paracrine5 or contact-dependent
signaling with other cell types, such as underlying stromal and
immune cells including macrophages, DCs, lymphocytes,
neutrophils, and mast cells.6,7 Summoning support from
underlying cells can assist in restoring the epithelial barrier or
initiate an immune response through expression of adhesion
molecules and release of mediators including cytokines and
chemokines.4 The synergistic interactions of cells within human
lung tissue remains largely understudied; in particular, few in
vitro lung models report the inclusion of immune cells that are
essential for sensing cellular and environmental changes as well
as exerting a crucial role in the pathogenesis of lung diseases.
The tissue engineering of lung models has largely focused
toward engineering tracheal replacements due to the simpler
nature of this tissue.8 The robust architecture of the trachea can
withstand the decellularization process and subsequent
repopulation, whereas it proves diﬃcult to repopulate
decellularized tissue from deeper within the lung that has a
more complex construction. The speciﬁc structural and cellular
architecture of complex lung tissue can be retained for
experimentation by using ex vivo tissue explants. These biopsy
samples are practical for short-term experimentation, though
interindividual variability can have an impact upon the results
and the availability of such tissue is limited. To allow high-
throughput screening of samples and, particularly, longer-term
experiments, it is preferable to have a sustainable source of
reproducible tissue models.
The use of commercially available two-dimensional (2D)
platforms upon which epithelial cells can be cultured at the air−
liquid interface (ALI) is widely practiced. Although information
regarding cellular interaction can be identiﬁed using these
methods, the 2D platforms fail to represent the cellular
arrangement seen in vivo and, therefore, are not amenable to
direct cell−cell interaction, thus only permitting observation of
paracrine interactions. The use of a 3D tissue equivalent is
favorable over 2D cell culture providing more in-vivo-like
morphology, function, and intercellular interactions enabling
greater resemblance to physiological conditions.9,10 Encapsulat-
ing cells within synthetic or natural hydrogels has been widely
used for culturing cells in a 3D environment and provide
greater cell−cell contact compared to culturing upon a solid 2D
substrate.11 In addition, hydrogels could provide a cellular
microenvironment resembling the native extracellular matrix
(ECM), hence supporting key functional properties of diﬀerent
cell types.12,13 Although many cell types seem to thrive within
the 3D environment of hydrogels, encapsulating epithelial cells
whose primary function is barrier formation could be
counterintuitive. Therefore, other types of 3D matrix such as
porous ﬁber sheets could be a favorable alternative for culturing
epithelial cells, providing closer morphological resemblance to
the basement membrane in barrier tissues such as skin and
respiratory epithelium.14 Obviously, this does not preclude use
of hydrogel based scaﬀolds with the optimal topography for 3D
culture of epithelial cells.
Methods to create ﬁbrous 3D platforms include phase
separation,15 electrospraying,16 or electrospinning.17 We show
that the ECM of lung tissue has a randomly arranged network
of nanometer-sized ﬁbers, and as such, the electrospinning
method proves a suitable choice to create a matrix that mimics
this arrangement for culturing lung associated cells. The porous
network of polymer ﬁbers that is produced can be tailored in
morphology and dimensions to mimic the native ECM of the
cells being cultured. Electrospun scaﬀolds may be constructed
from a plethora of materials. Although there has been some
success in the construction of pure protein electrospun
scaﬀolds (e.g., collagen18 and ﬁbrinogen19), poor structural
strength limits their use. Synthetic polymers oﬀer the choice of
well-deﬁned batches with a greater range of mechanical and
chemical properties than those of natural materials. Further-
more, synthetic polymers may adsorb ECM proteins in solution
or can be surface modiﬁed for enhanced cell attachment if
necessary.14,20 Synthetic polymers PLA and PLGA are the more
extensively studied, having been explored for both in vitro21
and in vivo research.22 However, PLA and PLGA are
biodegradable and, in our preliminary experiments, were
found to become quite fragile and diﬃcult to handle after
few days of cell culture, hence proving unsuitable to support
long-term cell cultures for the 3D lung model. Thus, use of
other nonbiodegradable and biologically nonfouling polymers
such as poly(ethylene terephthalate) (PET), which was
reported to support cell culture, was considered.23
Subsequently, in this study, we have used electrospun ﬁbers
of PET to create a 3D model of airway epithelium, comprising
epithelial cells, dendritic cells, and ﬁbroblasts, cultured at ALI.
The model has been characterized with regards to its barrier
function, responses to environmental stimuli, and migratory
properties of the immune cells after allergen challenge.
This model possesses reasonable cellular and structural
representation of the airway epithelium and is amenable to in
situ monitoring, and as such, it presents an invaluable tool for
academic and pharmaceutical research within the ﬁelds of lung
biology, disease modeling, and drug discovery and delivery.
■ EXPERIMENTAL SECTION
Materials. All materials were purchased from Sigma-Aldrich,
U.K., unless stated otherwise.
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Electrospinning Polyethylene Terephthalate Scaﬀold.
Electrospun scaﬀolds were produced by dissolving polyethylene
terephthalate (PET) in 1:1 triﬂuoroacetic acid (TFA):dichloro-
methane (DCM) (Fisher Chemicals, U.K.) to create a 10% (w/
v) solution. The polymer solution was loaded into a syringe (20
mL), and an 18 gauge needle (BD Falcon, U.K.) was attached.
The syringe was securely ﬁtted to a syringe pump-driver
(Harvard Apparatus Ltd., U.K.). The needle tip was positioned
15 cm from a grounded steel collector plate. The PET solution
was delivered at a constant ﬂow rate of 0.5 mL/hour at 14 kV
for 4 h. The scaﬀolds were air-dried in a fumehood for 24 h to
allow residual solvent to evaporate.
Propagation of Epithelial Cells and Fibroblasts. The
epithelial (Calu-3) and ﬁbroblast (MRC-5) cell lines (LGC
Standards cell, U.K.) were routinely cultured at 37 °C and 5%
CO2 in DMEM-F12 Ham or MEM media, respectively. Both
culture media were supplemented with fetal calf serum (FCS)
(10% (v/v)), L-glutamine solution (2 mM) (1% (v/v)), and an
antibiotic/antimycotic solution (1% v/v) comprised of
penicillin (10 000 units/mL), streptomycin sulfate (100 mg/
mL), and amphotericin B (25 μg/mL).
Generation of Dendritic Cells. Dendritic cells (DC) were
generated from peripheral blood monocytes as we have
previously described. Brieﬂy, peripheral blood mononuclear
cells were isolated from human blood buﬀy coat (National
Blood Transfusion Service, U.K.) using Histopaque density
gradient centrifugation. Monocytes were isolated using CD14+
magnetic beads (Milteny Biotech, U.K.) to the purity of
>98%.13,24 Puriﬁed monocytes were cultured with GM-CSF
(50 ng/mL) and IL-4 (250 IU/ml) (R&D Systems) for 6 days
to generate immature DCs. DC phenotype was determined by
ﬂow cytometry after staining for cell surface markers including
CD11c, CD83, CD83, and HLA-DR.25
Assembly of Epithelial−Fibroblast Cocultures. Electro-
spun scaﬀolds were cut to a size of 2 cm2 and sterilized by
irradiating with ultraviolet (UV) light at a distance of 8 cm for
15 min each side. The scaﬀolds were sterilely transferred to a 12
well culture plate and a steel ring was placed on top to secure
the scaﬀold before further sterilization in an antibiotic/
antimycotic solution overnight (37 °C, 5% CO2). The
sterilizing solution was removed and the scaﬀold washed with
PBS before submerging the scaﬀold in the appropriate cell
culture media to precondition the scaﬀold. Calu-3 and MRC-5
cells were inoculated inside of the steel ring onto separate PET
scaﬀolds at a density of 3 × 105 cells/scaﬀold (1 × 106 cells/mL
in 300 μL) and incubated for 72 h (37 °C, 5% CO2) (Figure
1A).
Following 72 h culture, single culture scaﬀolds were
transferred from steel rings into a polytetraﬂuoroethylene
(PTFE) platform support (ScaﬀHolder), which was designed
and fabricated in-house (Figure 1B−D). The epithelial scaﬀold
monolayer was placed on top of the ﬁbroblast scaﬀold layer
inside the ScaﬀHolder to form the coculture model. This layer-
on-layer approach is described in Figure 2. Single culture
controls were assembled by combination of either a Calu-3 or
MRC-5 scaﬀold with an acellular scaﬀold (i.e., without cells).
To ensure there is no possibility of separation or movement
during culture, scaﬀolds are secured in place within the
ScaﬀHolder. Alignment of cell layers is ensured because the
internal diameter of the steel ring matches that of the
ScaﬀHolder (Figure 1). The cells were submerged in cell
media for a further 12 h; the cell media for cocultures
comprised a 50:50 mixture of the MRC-5 and Calu-3 cell
media. Media from the apical surface of the ScaﬀHolder was
removed to culture epithelial cells at the ALI (Figure 1E).
Assembly of Epithelial−Dendritic−Fibroblast Tri-Cul-
tures. Epithelial−ﬁbroblast cocultures were assembled and
cultured for 14 days at the ALI prior to insertion of the DC
Figure 1. Steel rings are used to submerge the electrospun scaﬀolds
and deﬁne the cell seeding area (A). The use of ScaﬀHolders (B−E)
allow the 3D tissue engineered constructs of lung tissue to be cultured
under appropriate conditions where epithelial cells are at the ALI (E)
and ﬁbroblast cells remain submerged, mimicking in vitro lung
conditions.
Figure 2. Schematic ﬁgure showing diﬀerent steps of fabrication and
conﬁguration of the 3D tissue engineered airway epithelium. Calu-3
epithelial cells are seeded onto one PET scaﬀold and MRC-5
ﬁbroblasts are seeded onto a second, separate scaﬀold (A). Following
72 h culture, scaﬀolds are combined by layering the epithelial scaﬀold
monolayer on top of the ﬁbroblast scaﬀold layer to form the coculture
model. Cells are subsequently cultured for 2 weeks at the ALI to allow
for diﬀerentiation of the epithelial cells, including establishment of
tight junctions (B). Monocyte-derived DCs are seeded onto separate
PET scaﬀolds and then inserted into the coculture model. The upper
epithelial scaﬀold is temporally lifted away from the lower MRC-5
ﬁbroblast layer so that the separate third scaﬀold containing dendritic
cells may be placed on-top of the MRC-5 scaﬀold layer (C). The Calu-
3 layer is placed on-top of the DC scaﬀold layer, resulting in the DC
layer sandwiched between the epithelial and ﬁbroblast scaﬀold layers
to form the triculture model (D).
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layer. The cell culture media composition remained as a 50:50
mixture of Calu-3 and MRC-5 cell media.
Immature DCs (Day 6) were prestained with Hoescht
nuclear stain (5 μg/mL) (Invitrogen, U.K.) and inoculated
onto PET electrospun scaﬀolds at a density of 2 × 105 cells/
scaﬀold and incubated for 24 h (37 °C, 5% CO2). The culture
medium was aspirated to remove DCs that had not attached
prior to insertion in between Calu-3 and MRC-5 layers in an
established coculture model to form an immunocompetent
triculture model. A schematic describing the layer-on-layer
approach to assembling epithelial and ﬁbroblast cocultures and
subsequent insertion of the DC layer is described in Figure 2.
Stimulation of Triculture Model. Triculture models were
stimulated with house dust mite extract (HDM) (10 μg/mL)
(GREER, U.S.A.) and lipopolysaccharide (LPS) (100 ng/mL)
(Sigma-Aldrich, U.K.) or PBS control and incubated for 36 h
prior to analysis. The triculture models were ﬁxed with 4% (v/
v) paraformaldehyde (Electron Microscopy Sciences, U.S.A.) in
PBS, and the three scaﬀold layers were separated and
immunostained with pancytokeratin (epithelial cell marker).
Scaﬀolds were then examined by confocal microscopy (Leica
SP2 confocal laser scanning microscope) (Leica Microsystems
Ltd., U.K.) with postvisualization performed using Volocity
software (Perkin-Elmer, U.K.).
Trans-Epithelial Electrical Resistance Measurements.
Trans-epithelial electrical resistance (TEER) measurements
were performed across the epithelial cell monolayer of cells
cultured at the ALI. Measurements were performed using an
EVOM volt-ohm-meter and STX2 chopstick electrodes (World
Precision Instruments, U.K.). Prior to recording TEER,
chopstick electrodes were sterilized (70% v/v ethanol in
distilled water) and cell culture media was added to the upper
chamber (500 μL) and lower chamber (1.5 mL total volume)
and allowed to equilibrate for 30 min (37 °C, 5% CO2).
Control measurements were performed using acellular
scaﬀolds.
Scanning Electron Microscopy. Cellular samples of PET
electrospun scaﬀold were placed onto carbon-coated electron
microscope stubs and sputter-coated with gold (5 min, Blazers
SCD 030 Blazers Union Ltd., Liechtenstein) under an argon
atmosphere (BOC, U.K.) prior to analysis. Samples were
imaged using SEM (Scanning Electron Microscopy) analysis
(JEOL JMS-6060 LV microscope, JEOL Ltd., U.K.) operating
at an accelerating voltage of 10 kV. Cellular samples were ﬁxed
Figure 3. Comparisons of scanning electron micrographs of decellularised lung tissue (A) with PET electrospun scaﬀold (B) showing morphological
similarities. The ﬁber diameter of decellularised lung tissue and PET electrospun scaﬀolds were measured and show comparable dimensions (C).
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in 3% (v/v) glutaraldehyde overnight at 4 °C before
dehydration through an ascending series of ethanol concen-
trations prior to SEM imaging.
Scaﬀold Histology. Histology preparation was performed
by Nottingham University Advanced Microscopy Unit (AMU).
Brieﬂy, cellular scaﬀolds were ﬁxed with 10% buﬀered formalin,
excised, and embedded in paraﬃn. The paraﬃn embedded
blocks were then sectioned and stained with hematoxylin and
eosin (H&E) before imaging.
Immunocytochemistry. Scaﬀold samples were washed
with PBS prior to ﬁxation with paraformaldehyde (4% (w/v))
or methanol (100% (v/v)) for 15 min at room temperature
(RT). Samples were washed in PBS (3 × 5 min each) before
being permeabilized using Triton X-100 (0.5% (v/v)) for 5 min
at room temperature. Following a further wash in PBS (3 × 5
min each), nonspeciﬁc antibody binding was blocked with goat
serum (10% (v/v) in PBS for 5 min at room temperature.
Samples were incubated with primary antibody (1:100)
overnight at 4 °C. Primary antibodies used were Anti-Mucin
5AC [45M1] (ab3649, AbCam, U.K.), mouse anti-ZO1
(Invitrogen, U.K.), anti-ﬁbronectin (ab 23750, AbCam, U.K.),
Anti-Ki67 (ab15580, AbCam, U.K.), anti-collagen (ab34710,
AbCam, U.K.), and pan-cytokeratin PK110 (SantaCruz
Biotech, U.K.). Samples were then washed with PBS (3 × 5
min each) and incubated with species-appropriate ﬂuorescently
labeled secondary antibodies (1:100) for 30 min at room
temperature. Secondary antibodies included goat antimouse
IgG Rhodamine Red X (Invitrogen, U.K.), goat antirabbit IgG
FITC (Invitrogen, U.K.), and Alexa Fluor 488 goat antimouse
IgM (μ chain) (Invitrogen, U.K.). Samples were washed in PBS
(3 × 5 min each), incubated with Hoechst (5 μg/mL) for 5
min at room temperature, and mounted using Fluoromount
mounting medium. Immunostaining was observed using a
confocal microscope (Leica SP2 confocal laser scanning
microscope, images processed with Leica confocal software)
with postvisualization performed using Volocity software.
Application of Papain. A papain (60U/mL) solution was
prepared with L-cysteine (5 mM) to reconstitute the cysteine
active site, and an aliquot (300 μL) was applied to the apical
surface of Calu-3 cells. TEER measurements were performed to
monitor epithelial barrier integrity prior and post application.
■ RESULTS
The present study presents a multilayered 3D electrospun PET
lung model capable of incorporating multiple cell types each
supported upon their own individual electrospun layer. The
porous network of electrospun PET ﬁbers can permit cell
interaction through both direct cell−cell contact and paracrine
factors within the 3D model. We report the incorporation of
lung associated epithelial cells and ﬁbroblasts and monocyte-
derived DCs within the 3D model and determine how culturing
these cells together inﬂuences their behavior.
Assembly of 3D Coculture Lung Model. SEM analysis of
decellularised human lung tissue (from healthy sections of lung
tissue obtained from patients undergoing surgical procedures
(Nottingham University Hospitals NHS Trust) after informed
consent and ethics approval) revealed a porous network of
nanometer-sized ﬁbers (Figure 3A). Accordingly, we used a
nonbiodegradable polymer (namely, PET) to fabricate a
nanoscale porous scaﬀold (Figure 3B). The mean ﬁber
diameter of the PET scaﬀold (240 nm ±70) was similar to
the mean diameter of lung ECM (245 nm ±83) (Figure 3C).
The average thickness of the PET scaﬀold, calculated using
histological sections, was 60 ± 10 μm. Owing to its robust
physical properties, the PET electrospun scaﬀold is capable of
withstanding repeat handling allowing separation of individual
cell layers for assessment following experimentation.
The main structural cell types of the lung, epithelial, and
ﬁbroblast cells were each cultured upon separate PET scaﬀolds.
To incorporate an immune component into the model, a
triculture system was formed by culturing DCs upon a third
PET scaﬀold and inserting this between the epithelial and
ﬁbroblast layers of an established epithelial−ﬁbroblast coculture
(Figure 2).
Epithelial Barrier Formation and Integrity. Epithelial
and ﬁbroblast cells were each inoculated onto individual PET
scaﬀold layers and cultured submerged in media to allow cells
to establish growth upon the scaﬀold, following which the cell
inoculated scaﬀolds were assembled together within our
developed ScaﬀHolders allowing physiologically relevant
positioning of the construct. Epithelial cells were cultured
upon the uppermost layer allowing culture at ALI where the
upper cell surface is in contact with the air. Culturing epithelial
cells at the ALI mimics in vivo conditions by providing apical−
basal polarity, which leads to full diﬀerentiation of epithelial
cells and development of a functional barrier.26 The underlying
ﬁbroblasts were positioned directly beneath the epithelial
inoculated scaﬀold and remained submerged in media much as
they would in vivo.
The production and maintenance of barrier integrity in
epithelial cells cultured upon PET electrospun scaﬀolds and
positioned at the ALI using ScaﬀHolders was assessed using
TEER measurements and permeability studies. Barrier
formation was compared when epithelial cells were cultured
alone (single culture) or with ﬁbroblasts (coculture). TEER is
widely used to monitor barrier integrity, where an increase in
resistance to ﬂow of current is due to greater integrity of the
barrier, attributed to the formation of cellular tight junctions.27
An acellular control scaﬀold was monitored in order to
report a control value, as it is known that TEER values
reportedly vary according to the material upon which the
epithelial cells are cultured.28 In addition, a single culture of
MRC-5 ﬁbroblasts was monitored as a control, as an increase in
TEER value was not expected owing to MRC-5 ﬁbroblasts
characteristically not forming tight junctions.
Statistical analysis was performed using two-way ANOVA
with Sidaks̀ multiple comparison showed that TEER measure-
ments of cocultures produced readings that were signiﬁcantly
greater than those of epithelial cells cultured alone (Figure 4A).
The TEER measurements show that after 14 days in culture
epithelial cells cultured alone, without ﬁbroblasts, attained
measurements of ∼130 Ω cm2. The greatest increase was seen
for cocultures of epithelial and ﬁbroblast cells attaining
measurements of ∼200 Ω cm2. Thus, epithelial cells cultured
together with ﬁbroblasts appeared to achieve a conﬂuent
diﬀerentiated state earlier than single cultures of epithelial cells
as shown by earlier and greater increases in TEER measure-
ments (Figure 4 A). The TEER values of the controls, an
acellular scaﬀold and MRC-5 single culture, did not increase,
maintaining baseline TEER measurements of ∼100 Ω cm2.
Although human lung ex vivo TEER results are not available in
the literature, ex vivo rabbit airway epithelium has been
reported to be 260−320 Ω cm2 for the trachea29 and 266 Ω
cm2 for the bronchus.30 Thus, the maximal TEER recorded in
our 3D model are comparable to the data available for animal
ex vivo TEERs.
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The topography of the conﬂuent epithelial cell layer was
observed using SEM. The SEM micrographs of epithelial cells
from single culture, coculture, and ﬁbroblasts from cocultures
showed what is thought to be the presence of ECM protein
deposition (Figure 4B).
H&E staining of the epithelial layer from single and
cocultures indicated that single cultures formed a single thin
layer of cells, whereas the cocultured epithelial cells had a more
dense and layered arrangement after 14 days at ALI (Figure 5).
Furthermore, epithelial cells within cocultures appeared to
produce mucus earlier than single cultures as shown by
immunocytochemical staining (Figure 5).
Immunocytochemical staining of the deposition of ECM
proteins indicated that the epithelial cells deposit collagen and
ﬁbronectin when cultured upon PET electrospun scaﬀolds
(Figure 6). There appeared to be enhanced production of these
ECM proteins from cocultured epithelial cells. The expression
of the cell proliferation marker Ki67 showed that epithelial cells
in coculture had lower levels of Ki67, possibly indicating their
tendency toward an earlier full diﬀerentiated state as also
evidenced by an accelerated increase in TEER readings in
cocultures compared with single cultures of epithelial cells
(Figure 7A). Fibroblast cell growth has not been adversely
aﬀected when positioned beneath the epithelial cell layer during
coculture experimentation; the ﬁbroblast cells are still present
and in a state of active growth as indicated by the production of
Ki67 and have retained the ability to produce ECM proteins
collagen and ﬁbronectin (Figure 6).
Epithelial Repair. The 3D lung model was cultured at the
ALI for 14 days before papain was applied to the epithelial
surface of single and cocultures. Papain is an allergen with
cysteine protease activity and is known to disrupt tight
junctions in respiratory epithelium using its enzymatic activity,
mimicking the action of other airborne allergens such as house
dust mite, which also have a cysteine protease activity.31 The
application of papain on day 14 ALI was shown to disrupt
epithelial tight junctions in both single and coculture as
demonstrated by a sharp reduction in TEER values (Figure 7A)
and disintegration of ZO1 protein visualized by immunostain-
ing followed by confocal imaging (Figure 7B). The disruption
to tight junctions from coculture was thought to be less than
that of single cultures, where almost no ZO1 could be observed
post papain. TEER measurements were performed for a further
14 days to monitor the epithelial repair process, and further
Figure 4. The TEER measurements of cocultures are signiﬁcantly
higher than those of epithelial cells cultured alone. Error bars show
standard error of the mean. Statistical analysis was performed using
two-way ANOVA with Sidaks̀ multiple comparison with the diﬀerence
between coculture and single Calu-3 culture having a p value <0.0001
(A). SEM images of epithelial cells from single and coculture where
the upper surface that has been imaged is thought to be predominantly
formed from ECM protein presence. The micrographs show that
epithelial cells from coculture have a smoother surface than those from
single culture (B).
Figure 5. After 14 days at the ALI. Histological staining shows the
presence of epithelial cells on the uppermost surface of the PET
scaﬀold with a greater number of cells found in cocultures compared
to single cultures. Mucin production (red) was greater from coculture
than single culture, where cell nuclei are stained with DAPI (blue).
Figure 6. ECM staining following 14 days culture at the ALI shows the
presence of ECM proteins: collagen and ﬁbronectin, predominantly
found in epithelial and ﬁbroblast cells and also Ki67, showing that the
cells are in active growth. Epithelial cells in cocultures appear to
express lower levels of Ki67 (compared to single cultures), indicating
their tendency toward full diﬀerentiation.
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examination of ZO1 expression was carried out. The cocultures
were observed to be recovering from the disruption with
increased TEERS and increased presence of ZO1 (Figure 7A
and B). However, TEER measurements did not appear to
recover in single cultures during the same time frame and
remained at approximately the same value as when the cells
were subjected to papain (Figure 7A). The confocal microscopy
images on day 15 (post papain) of single culture shows that the
cell growth has been disrupted by papain and that tight
junctions are not present over a wide area of the sample. The
cells from single cultures recovered slightly as evidenced by the
presence of nondisrupted nuclei on day 28; however, the
presence of tight junctions remain absent (Figure 7B).
DC Migration within the 3D Triculture Model. In a
proof-of-concept experiment, an immunocompetent triculture
model comprising of epithelial, dendritic, and ﬁbroblast layers
was constructed and DC migration within the model
monitored. The triculture model was stimulated with HDM
extract (a common airborne allergen) and toll-like 4 receptor
agonist LPS (abundant in most airborne bacterial pathogens),
and subsequently, the migration of DCs was assessed by
confocal microscopy. Epithelial cells were identiﬁed using
pancytokeratin and DCs had been prestained using the nuclear
stain Hoescht.32 Assessment of the uppermost scaﬀold (bearing
epithelial cells) revealed that after 36 h in the triculture, most
DCs seemed to have migrated to this layer and were present in
close proximity to the basal (in unstimulated samples) or apical
side (in stimulated samples) of the epithelial cell layer (Figure
8A). The DCs migration was further conﬁrmed by the fact that
DCs were found to be largely absent from the scaﬀold upon
which they were originally inoculated (middle scaﬀold) (Figure
8B). Typically, not many DCs could be observed in the
majority of lower scaﬀolds (ﬁbroblast layer) in either stimulated
or unstimulated samples (Figure 8C).
■ DISCUSSION
Using electrospun porous ﬁbers, we have engineered a 3D
triculture of airway epithelial cells, dendritic cells, and
ﬁbroblasts at ALI creating a modular construct that mimics
the cellular orientation and some functional properties of
human airway epithelium. The epithelium in vivo provides the
ﬁrst line of defense against environmental insults, and as such, it
is capable of rapidly repairing any cellular damage caused.
Epithelial cells in vivo are thought to respond to insult and
injury through a cascade of events of which there are three
distinct stages: dediﬀerentiation, proliferation, and diﬀer-
entiation.33 The ﬁrst stage is the dediﬀerentiation of underlying
stromal cells, such as ﬁbroblasts, that are initially exposed to the
environment following injury to epithelial cells. The stromal
cells are thought to migrate to the wound site to assist repair by
dediﬀerentiation helping to cover the site of injury and assist in
restoring barrier integrity through proliferation.34 The ﬁnal
Figure 7. Following the 14 days at the ALI, the enzyme papain was
applied to the epithelial surface of single and cocultures, which was
shown to disrupt tight junctions demonstrated by the measurement of
TEERs (A) and by confocal imaging of ZO1 protein (B). The
disruption to tight junctions from coculture was observed to be less
than that of single cultures. TEER measurements were then performed
for a further 14 days to monitor the healing process. The cocultures
were observed to be recovering from the disruption with increase in
TEERS and increase in the presence of ZO1. Single cultures did not
appear to recover so well with TEER measurements remaining around
the same value as when the cells were subjected to papain. Statistical
analysis was performed using two-way ANOVA with Sidaks̀ multiple
comparison, showing that the diﬀerence between coculture and single
Calu-3 culture that had been subjected to papain having a p value
<0.0001.
Figure 8. Confocal microscopy images (×10 mag) of DC migration 36
h after allergen stimulation in 3D tricoculture. The upper scaﬀold
contained the Calu-3 epithelial layer (A), a middle layer to which DCs
were seeded (B), and a lower scaﬀold containing MRC-5 (C). DCs
were prestained with Hoescht nuclear stain (blue) and Calu-3 cells
were poststained with pancytokeratin (green). In single culture, DCs
remained on the middle scaﬀold where they had been inoculated. In
the triculture, most DCs migrated from middle scaﬀold (B) to upper
scaﬀold (A). Upon treatment of the triculture with house dust mite
extract (HDM) (10 μg/mL) and lipopolysaccharide (LPS) (100 ng/
mL), DCs appeared to primarily migrate to the apical surface of the
epithelial layer, whereas in unstimulated samples they appear to be
mainly localized in the basal region of the epithelial layer (A).
Experiments were performed in duplicates.
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stage in restoring barrier integrity is the diﬀerentiation of cells
involved in the repair process, including the restoration of full
function to epithelial cells, particularly their ability to form
junctional protein to “seal” the barrier.35
The exact mechanisms controlling cell fate during epithelium
repair are not clear; however, it is thought that multiple
paracrine factors and direct cell−cell contact are key parameters
required to restore barrier integrity and function.36 It is,
therefore, important to consider these factors when conﬁguring
tissue engineering strategies to create in vitro models of
epithelial tissue.36b
This study developed a 3D multicellular lung model that is
capable of forming a more physiologically relevant representa-
tion of lung tissue than culturing cells alone or in 2D systems.
Our studies corroborate the relevance of culturing multiple cell
types found in lung tissue together, as results demonstrate that
when epithelial cells were subjected to chemical insult (i.e., an
enzymatically active allergen), they recovered earlier in
cocultures than single cultures. This supports the relevance of
cocultures as it is thought that the cells signal and respond in
alliance.
This study also assembled a triculture model in a proof-of-
concept experiment to examine whether DC migration could
occur within the lung model following stimulation.
A large number of DCs were found to migrate from the
scaﬀold in which they were initially inoculated (middle layer)
through to the uppermost scaﬀold bearing the epithelial cells.
This occurred both in the presence and absence of stimulation
and may suggest that DCs were responding to epithelial
secretions.37 However, in samples stimulated with LPS and
HDM, most DCs were located closer to the apical side of the
epithelial barrier, whereas in unstimulated samples they were
mainly located close to the basal side. These results prove that
the 3D lung model is amenable to cell migration and that cell−
cell contact is feasible. Individual scaﬀolds are typically 60 ± 10
μm thick and the results of the DC migration study
demonstrate that scaﬀold thickness does not seem to impede
DC migration. The pattern of migration observed in this
experiment substantiates DC migration in vivo, where upon
activation, DCs migrate to the epithelium and survey the
immune environment before migrating through the subepithe-
lial compartment before traveling to lymph nodes.7,37,38 This
enables future studies focused on inhaled drug delivery systems
as well as allergen and inhaled drugs uptake by DCs. We would
estimate the triculture would be limited to one week due to
migration of DCs and their phenotypical/functional changes
upon stimulation, which should provide enough time for
performing drug uptake/delivery experiments. Limitations to in
vitro models, particularly those generated from commercially
available 2D inserts, are that the surface upon which cells grow
is planar, so cell−cell interaction is restricted. Cell interactions
can occur through the pores of the insert; however, these are
thought to be constrained to paracrine interactions because the
pore size of the substrate upon which the epithelial cells are
commonly cultured to allow barrier formation are too small,
thus preventing cell migration. A 3D human skin triculture
model comprising of keratinocytes, DCs, and ﬁbroblasts has
been reported.14 This model shares similarities with the model
developed in this work, including a physiologically relevant
arrangement of the cell layers each supported on separate 3D
scaﬀolds and the establishment of a diﬀerentiated epithelial−
ﬁbroblast coculture prior to DC insertion. In the skin triculture
model, the keratinocytes and ﬁbroblasts were supported on 3D
microﬁber-scale scaﬀolds; however, the DC layer was inserted
into the model in an agarose gel rather than on a ﬁbrous
scaﬀold. Migration of DCs in the skin model was reported from
the agarose gel layer to only the ﬁbroblast layer. Furthermore,
the degree of migration appeared to be far less than that
observed in the 3D model developed in this study. Hence,
direct seeding of DCs on the porous scaﬀolds as opposed to
encapsulation within a hydrogel seems to facilitate cell
migration.
Epithelial cell lines such as Calu-3, the cell line we have used
in this study, are widely used as surrogates for primary cells.39
Despite many similarities between Calu-3 and primary cells,
particularly in features like barrier formation and mucus
production, there are also considerable functional diﬀerences
(e.g., their cytokine proﬁle). Therefore, use of cell lines
somewhat limits the physiological relevance of the model and
future eﬀorts should focus on replacing cell lines with human
primary cells.
The 3D immunocompetent lung model presented in this
study successfully supports the culture of multiple cell types on
electrospun PET scaﬀolds that structurally resemble the native
lung ECM. The porous network of electrospun PET ﬁbers can
permit cell interaction through both direct cell−cell contact and
through paracrine factors within the 3D model as shown by the
enhanced formation of a diﬀerentiated epithelial layer,
enhanced epithelial repair, and migration of immune cells
incorporated within the model. Furthermore, the modular
nature of our approach means that other relevant structural
(e.g., smooth muscle cells) and immune cells (e.g., mast cells or
eosinophils) could be included into the model with relative
ease.
Collectively, we believe this model possesses adequate
cellular and structural representation of the airway epithelium
and is amenable to in situ monitoring; as such, it presents an
invaluable tool for academic and pharmaceutical research within
the ﬁelds of lung biology, disease modeling, and drug discovery
and delivery with the potential of reducing the need for some
animal experimentation in this area.
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